InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.100 0.013 (14.94%)+
Announcement
Release
19 Aug 2026 7:58AM
Price at Release
$0.087
Full Release
download
Summary
The FY26 Annual Report of Alcidion Group Limited highlights a strong financial and operational performance. For the fiscal year ending 30 June 2026, the company reported a 27% increase in revenue, reaching $51.6 million, and a 34% increase in underlying EBITDA to $6.8 million. The profit after tax attributable to owners rose to $2.3 million. Annual recurring revenue grew by 23% to $31.9 million, with forward FY27 recurring revenue projected at $38.3 million. The company maintained positive operating cash flow and ended the year with $20.6 million in cash, having no debt, and completed a strategic acquisition of Kyra flow products from Telstra Health. The growth was driven by commercial momentum in ANZ and the UK, alongside significant customer contracts and expansions.
Key Points
  • Revenue increased by 27% to $51.6 million in FY26.
  • Underlying EBITDA rose by 34% to $6.8 million.
  • Profit after tax for owners increased to $2.3 million.
  • Annual recurring revenue grew by 23% to $31.9 million.
  • Forward FY27 recurring revenue projected at $38.3 million.
  • Positive operating cash flow of $6.8 million.
  • Ended the year with $20.6 million in cash and no debt.
  • Acquired Kyra flow products from Telstra Health.
  • Growth driven by commercial momentum in ANZ and the UK.
  • Significant customer contracts and expansions in FY25 and FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.